Guide to urine testing in drug abuse prevention and multi-modality treatment programs.
D000662:Amphetamines / Q000652:urine; D000701:Analgesics, Opioid / Q000652:urine; D014151:Anti-Anxiety Agents / Q000652:urine; D000929:Antidepressive Agents, Tricyclic / Q000652:urine; D014150:Antipsychotic Agents / Q000652:urine; D001569:Benzodiazepines; D002849:Chromatography, Gas; D002853:Chromatography, Liquid; D002855:Chromatography, Thin Layer; D003042:Cocaine / Q000652:urine; D003061:Codeine / Q000652:urine; D003365:Costs and Cost Analysis; D006213:Hallucinogens / Q000652:urine; D003932:Heroin / Q000652:urine; D006801:Humans; D006993:Hypnotics and Sedatives / Q000652:urine; D007118:Immunoassay; D013058:Mass Spectrometry; D009292:Narcotic Antagonists / Q000652:urine; D009294:Narcotics / Q000652:urine; D010640:Phenothiazines; D011343:Procaine / Q000652:urine; D011803:Quinine / Q000652:urine; D013050:Spectrometry, Fluorescence; D019966:Substance-Related Disorders / Q000652:urine*; D009626:Terminology as Topic; D014556:Urine / Q000032:analysis*
D000662:Amphetamines; D000701:Analgesics, Opioid; D014151:Anti-Anxiety Agents; D000929:Antidepressive Agents, Tricyclic; D014150:Antipsychotic Agents; D006213:Hallucinogens; D006993:Hypnotics and Sedatives; D009292:Narcotic Antagonists; D009294:Narcotics; D010640:Phenothiazines; D001569:Benzodiazepines; D011343:Procaine; D003932:Heroin; D011803:Quinine; D003042:Cocaine; D003061:Codeine